A19 Ras/Raf/MEK/ERK pathway is required for increased expression of MMP-13 in human chondrocytes by type II collagen-dependent activation of DDR2  by unknown
$20 Podium Presentations 
Subject characteristics at 1st assessment 
Radiographic OA No radiographic OA 
n=134 n=129 
Age (mean years) 53.6 50.4 
Sex (% women) 25 16 
BMI (mean kg/m 2) 26.9 25.5 
Time between 1st and 2nd 
assessment (mean years) 7.7 7.4 
Increase in pain considered 
clinically relevant (% subjects) 37 22 
Change in KOOS pain score 
(mean; 95% CI) -7; -3.4, -10.7 -2.5; 0.3, -5.4 
BMI = body mass index, KOOS = Knee injury and Osteoarthritis Outcome 
Score 
over-the-counter drugs, NSAID, or glucosamine sulphate for knee 
pain was more frequent in subjects who reported a clinically rele- 
vant increase in knee pain (_>10 KOOS points) than subjects who 
did not (16% vs. 6%; P = 0.008). 
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Fig. 1. Change in the Knee injury and Osteoarthritis Outcome Score (KOOS) 
for the dimension pain. Patients are divided into subjects with and without ra- 
diographic knee OA at the 1st assessment, but also 3 subgroups according 
to the score at entry. Each line represents 1 patient visualizing the score 
at the 1st assessment (left endpoint of line) and the 2nd assessment in 
2004 (right endpoint of the same line). Please note, several lines showing 
no change in pain (100-100) overlap. 
Conclusions: Over a period of 6-9 years, nearly 40% of menis- 
cectomized subjects with radiographic knee OA report worsening 
in knee pain that is considered clinically relevant. Increased knee 
pain was mostly seen in subjects who were pain free at entry. 
The young age of this cohort constitutes a strong reason to di- 
rect increased efforts toward prevention and better treatment of 
meniscal injury and knee OA. 
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In previous studies, we demonstrated that activation of discoidin 
domain receptor 2 (DDR2, a cell membrane tyrosine kinase), 
which binds preferentially to type II collagen, induces high lev- 
els of expression of MMP-13 in chondrocytes, but not other car- 
tilage matrix-degrading proteinases. We also found that inhibi- 
tion of MEK by PD98059 reduced the expression of MMP-13 in 
human chondrocytes cultured on type II collagen-coated plates, 
suggesting involvement of the Ras/Raf/MEK/ERK pathway. To 
further characterize this response, we performed the following 
experiments. 1) Human chondrocytes were transfected with a 
full-length cDNA of human Raf kinase inhibitor protein (hRKIP) 
and cultured on type II collagen-coated plates for 24 h. Results 
showed that M M P - 13 m R NA levels, examined by real-tim e PC R, 
were reduced about 60% in chondrocytes overexpressing hRKIP 
compared with cells expressing the empty vector control. 2) We 
examined the phosphorylation of three kinases, ERK, JNK and 
p38, in human chondrocytes after culture on type II collagen- 
coated plates for 2 h. Only ERK was phosphorylated further sug- 
gesting the DDR2-mediated response to type II collagen occurs 
via the ERK pathway. 3) Human chondrocytes were transfected 
with the MMP-13 promoter-luciferase construct cultured on type 
II collagen-coated plates for 24 h. Results showed that the MMP- 
13 promoter activity was increased by about 2-fold, suggesting 
that DDR2 response is at least partially transcriptional. 4) Human 
chondrocytes were first treated for 4 h with either an activating or 
a neutralizing alpha2betal integrin antibody and then cultured on 
plastic or type II collagen-coated plates for 24 h. Results showed 
that activating alpha2betal integrin antibody, which did not induce 
DDR2, and type II collagen had a synergistic (additive) effect 
in the induction of MMP-13 mRNA levels, suggesting that type 
II collagen-dependent DDR2 and alpha2betal integrin regulate 
MMP-13 expression through different signaling pathways. In sum- 
mary, this study provides further evidence that activation of DDR2 
increases the expression of MMP-13 via the Ras/Raf/MEK/ERK 
pathway in chondrocytes. 
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Aim of Study: The study was performed to elucidate the mech- 
anism(s) involved in the dedifferentiation in monolayer cultured 
adult human articular chondrocytes. 
Methods: The study was performed under the approval of insti- 
